A partnership between AI specialist Owkin and drugmaker AstraZeneca has been formed to find tools that can be applied to digitised pathology slides, acting as a 'pre-screen' for BRCA mutations ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

AION was created through an alliance of four pharma companies, AstraZeneca ... The company recently made an investment in AI-focused Owkin, with the goal of discovering new biomarkers and ...

AstraZeneca Pharma India Ltd on Thursday announced a strategic collaboration with the Indian Academy of Paediatrics to raise awareness on Respiratory Syncytial Virus (RSV) that can put newborn pre ...

CAMBRIDGE, England, November 12, 2024--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16,932.38 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

After hours: November 15 at 7:54 PM EST Loading Chart for AZN ...

As of November 13, 2024, AstraZeneca PLC had a $199.9 billion market capitalization, putting it in the 99th percentile of companies in the Pharmaceuticals industry. Currently, AstraZeneca PLC’s ...

The attack came just days after President Biden gave Ukraine permission to use the weapons to strike targets inside Russia. By Marc Santora and Eric Schmitt The envoy, Amos Hochstein, said an ...

On 1,000th day of war, Ukraine hits targets inside Russia with U.S.-made missile system One thousand days ago, Russia launched its full-scale invasion of Ukraine. Ukraine marked that grim ...